Kelly Schwartz
- Psychiatry and Mental health top 5%
- Pharmacology top 5%
- Pediatrics, Perinatology and Child Health top 10%
- Cellular and Molecular Neuroscience top 10%
- Experimental and Cognitive Psychology top 10%
- Co-authors
- Russell L. KoltsArif KhanKenneth AlperWalter A. BrownCharles G. LineberryDerry RidgwayDonald S. Robinson
- Topics
- Treatment of Major Depression (5 papers)Schizophrenia research and treatment (3 papers)Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (2 papers)
- Partner nations
- United States
In The Last Decade
Kelly Schwartz
8 papers receiving 646 citations
Peers
Comparison fields: 5 of 79
- Psychiatry and Mental health 324
- Pharmacology 172
- Pediatrics, Perinatology and Child Health 158
- Cellular and Molecular Neuroscience 124
- Experimental and Cognitive Psychology 89
Countries citing papers authored by Kelly Schwartz
This map shows the geographic impact of Kelly Schwartz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kelly Schwartz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kelly Schwartz more than expected).
Fields of papers citing papers by Kelly Schwartz
This network shows the impact of papers produced by Kelly Schwartz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kelly Schwartz. The network helps show where Kelly Schwartz may publish in the future.
Co-authorship network of co-authors of Kelly Schwartz
This figure shows the co-authorship network connecting the top 25 collaborators of Kelly Schwartz. A scholar is included among the top collaborators of Kelly Schwartz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kelly Schwartz. Kelly Schwartz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 325 | |
| 2 | 15 | |
| 3 | 12 | |
| 4 | 13 | |
| 5 | 39 | |
| 6 | 50 | |
| 7 | 187 | |
| 8 | Study designs and outcomes in antidepressant clinical trials. | 33 |
About Kelly Schwartz
Kelly Schwartz is a scholar working on Pharmacology, Behavioral Neuroscience and Geriatrics and Gerontology, having authored 8 papers that have together received 674 indexed citations. Recurring topics across this work include Treatment of Major Depression (5 papers), Schizophrenia research and treatment (3 papers) and Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (2 papers). The work is most often cited by research in Biological Psychiatry (78 citations), Behavioral Neuroscience (80 citations) and Psychiatry and Mental health (324 citations). Kelly Schwartz has collaborated with scholars based in United States. Frequent co-authors include Russell L. Kolts, Arif Khan, Kenneth Alper, Arif Khan, Walter A. Brown, Charles G. Lineberry, Derry Ridgway and Donald S. Robinson. Their work appears in journals such as Biological Psychiatry, Neuropsychopharmacology and Journal of Affective Disorders.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.